| Date Filed | Type | Description |
| 10/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2023 |
4
| Chopra Daveen (CVP, TMTT) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Sold 8,500 shares
@ $70, valued at
$595k
Exercised 8,500 options to buy
@ $59.2567, valued at
$503.7k
|
|
| 10/02/2023 |
4
| MUSSALLEM MICHAEL A (Director) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Sold 29,350 shares
@ $68.84, valued at
$2M
Exercised 29,350 options to buy
@ $36.75, valued at
$1.1M
|
|
| 09/29/2023 |
4
| Ullem Scott B. (CVP, CFO) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Sold 7,255 shares
@ $69.542, valued at
$504.5k
Exercised 7,255 options to buy
@ $36.75, valued at
$266.6k
|
|
| 08/25/2023 |
3
| Markowitz Wayne (GM & SVP, Surgical) has filed a Form 3 on Edwards Lifesciences Corp |
| 08/14/2023 |
4
| BOBO DONALD E JR (CVP,Strategy/Corp Development) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Sold 4,500 shares
@ $79.3, valued at
$356.9k
Exercised 4,500 options to buy
@ $36.75, valued at
$165.4k
|
|
| 08/14/2023 |
4
| Wood Larry L (Global President TAVR & Surg) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Sold 6,421 shares
@ $79.3, valued at
$509.2k
Exercised 6,421 options to buy
@ $45.2767, valued at
$290.7k
|
|
| 08/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/10/2023 |
4
| STONE HEISZ LESLIE (Director) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Sold 3,303 shares
@ $78.8703, valued at
$260.5k
|
|
| 08/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/09/2023 |
4
| Szyman Catherine M. (CVP, Critical Care) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Sold 5,000 shares
@ $78.637, valued at
$393.2k
Exercised 5,000 options to buy
@ $36.75, valued at
$183.8k
|
|
| 08/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/07/2023 |
4
| MUSSALLEM MICHAEL A (Director) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Sold 300 shares
@ $80.54, valued at
$24.2k
Sold 29,050 shares
@ $79.86, valued at
$2.3M
Exercised 29,350 options to buy
@ $36.75, valued at
$1.1M
|
|
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/26/2023 |
8-K
| Quarterly results |
| 07/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/10/2023 |
4
| Szyman Catherine M. (CVP, Critical Care) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Paid exercise price by delivering 252 shares
@ $90.46, valued at
$22.8k
Sold 5,000 shares
@ $90.52, valued at
$452.6k
Exercised 5,000 options to buy
@ $36.75, valued at
$183.8k
|
|
| 07/07/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2023 |
4
| MUSSALLEM MICHAEL A (Director) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Sold 7,622 shares
@ $91.22, valued at
$695.3k
Sold 21,728 shares
@ $90.63, valued at
$2M
Exercised 29,350 options to buy
@ $36.75, valued at
$1.1M
|
|
| 06/30/2023 |
4
| Ullem Scott B. (CVP, CFO) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Sold 7,255 shares
@ $93.27, valued at
$676.7k
Exercised 7,255 options to buy
@ $36.75, valued at
$266.6k
|
|
| 06/01/2023 |
4
| MUSSALLEM MICHAEL A (Director) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Sold 5,300 shares
@ $83.43, valued at
$442.2k
Sold 5,396 shares
@ $85.08, valued at
$459.1k
Sold 18,654 shares
@ $84.57, valued at
$1.6M
Exercised 29,350 options to buy
@ $36.75, valued at
$1.1M
|
|
| 06/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/24/2023 |
4
| Wood Larry L (Global President TAVR & Surg) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Sold 6,421 shares
@ $84.23, valued at
$540.8k
Exercised 6,421 options to buy
@ $45.2767, valued at
$290.7k
|
|
| 05/24/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/17/2023 |
4
| Ullem Scott B. (CVP, CFO) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Gifted 8,496 shares
@ $0
Gifted 8,496 shares
@ $0 |
|
| 05/15/2023 |
4
| SELLERS ROBERT W.A. (SVP, Corporate Controller) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Granted 1,800 shares
@ $0
Granted 5,540 options to buy
@ $88.78, valued at
$491.8k
|
|
| 05/15/2023 |
4
| Wood Larry L (Global President TAVR & Surg) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Granted 7,775 shares
@ $0
Granted 65,700 options to buy
@ $88.78, valued at
$5.8M
Granted 9,725 options to buy
@ $0 |
|
| 05/15/2023 |
4
| Lemercier Jean-Luc M (CVP, EMEACLA and JAPAC) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Granted 1,575 shares
@ $0
Granted 13,300 options to buy
@ $88.78, valued at
$1.2M
Granted 1,975 options to buy
@ $0 |
|
| 05/15/2023 |
4
| Zovighian Bernard J (President) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Granted 22,525 shares
@ $0
Granted 173,700 options to buy
@ $88.78, valued at
$15.4M
Granted 28,150 options to buy
@ $0 |
|
|